Trials / Unknown
UnknownNCT06234436
Plasma Dilution and Infusion to Improve Cognition in Mild Cognitive Impairment (MCI)
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In the ADDITION-MCI project, patients with a diagnosis of mild cognitive impairment probably caused by Alzheimer's disease will receive plasma exchange.
Detailed description
Repeated plasma exchanges will be conducted, and cognitive outcomes will be measured before and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Plasma exchenge | Plasma exchange will be conducted. The substitution fluid will be plasma from ha healthy donor. |
Timeline
- Start date
- 2023-12-07
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2024-01-31
- Last updated
- 2024-01-31
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT06234436. Inclusion in this directory is not an endorsement.